A rewarding research pathway

Annual Review of Pharmacology and Toxicology

Volumn 37, Issue , 1997, Pages 1-28

  Goldstein, Avram ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

addiction; biotechnology; drug abuse; dynorphin; endorphins; Stanford

Indexed keywords

CAFFEINE; DYNORPHIN; ENDORPHIN; OPIATE PEPTIDE; OPIATE RECEPTOR;

BIOTECHNOLOGY; DRUG ABUSE; DRUG DEPENDENCE; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030960229     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.37.1.1     Document Type: Review

References (54)

1. Krayer O, Goldstein A, Plachte FL. 1944. Studies on physostigmine and related substances. I. Quantitative relation between dosage of physostigmine and inhibition of cholinesterase activity in the blood serum of dogs. J. Pharmacol. Exp. Ther. 80:8-30
2. Chapman EM, Goldstein A. 1943. The physics of sound with particular relation to examination of the patient. J. Lab. Clin. Med. 28:1535-41
3. Goldstein A. 1944. The mechanism of enzyme-inhibitor-substrate reactions. Illustrated by the cholinesterase-physostigmine-acetylcholine system. J. Gen. Physiol. 27:529-80
4. Goldstein A. 1949. A "free manometer" technique for use with the Warburg apparatus. Science 110:400
5. Goldstein A. 1949. The interactions of drugs and plasma proteins. Pharmacol. Rev. 1:102-65
6. Luria SE, Delbruck M. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511
7. Goldstein A, Magasanik B, Umbarger HE. 1955. On the mechanism of development of resistance to streptomycin in Micrococcus pyogenes Var. Aureus. J. Bacteriol. 70:620-21
8. Goldstein A. 1987. Otto Krayer. In Biographical Memoirs, 57:150-225. Washington, DC: Natl. Acad. Press
9. Goldstein A. 1964. Biostatistics: An Introductory Text. New York: Macmillan. 272 pp.
10. Watson JD, Crick FHC. 1953. Molecular structure of nucleic acid. A structure for deoxyribose nucleic acid. Nature 171:737-38
11. Goldstein A, Brown BJ. 1961. Addition of amino acid to C-terminal ends of growing protein chains in Escherichia coli. Biochim. Biophys. Acta 53:438-39
12. Goldstein A, Kirschbaum JB, Roman A. 1965. Direction of synthesis of messenger RNA in cells of Escherichia coli. Proc. Natl. Acad. Sci. USA 54:1669-75
13. Riggs DS, Goldstein A. 1961. Equation for inert gas exchange which treats ventilation as cyclic. J. Applied Physiol. 16:531-37
14. Goldstein A, Aronow L, Kalman SM. 1968. Principles of Drug Action: The Basis of Pharmacology. New York: Hoeber-Harper & Row. 884 pp.
15. Goldstein A, Warren R, Kaizer S. 1965. Psychotropic effects of caffeine in man. I. Individual differences in sensitivity to caffeine-induced wakefulness. J. Pharmacol. Exp. Ther. 149:156-59
16. Goldstein A, Kaizer S, Warren R. 1965. Psychotropic effects of caffeine in man. II. Alertness, psychomotor coordination, and mood. J. Pharmacol. Exp. Ther. 150:146-51
17. Goldstein A, Kaizer S. 1969. Psychotropic effects of caffeine in man. III. A questionnaire survey of coffee drinking and its effects in a group of housewives. Clin. Pharmacol. Ther. 10:477-88
18. Goldstein A, Kaizer, S, Whitby O. 1969. Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clin. Pharmacol. Ther. 10:489-97
19. Dole VP, Nyswander M. 1965. Amedical treatment for diacetylmorpnine (heroin) addiction. J. Am. Med. Assoc. 193:80-84
20. Goldstein A, Lowney LI, Pal BK. 1971. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proc. Natl. Acad. Sci. USA 68: 1742-47
21. Pert CB, Snyder SH. 1973. Opiate receptor: demonstration in nervous tissue. Science 179:1011-14
22. Simon EJ, Hiller JM, Edelman I. 1973. Stereospecific binding of the potent narcotic analgesic 3-etorphine to rat brain homogenate. Proc. Natl. Acad. Sci. USA 70:1947-49
23. Terenius L. 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat brain cortex. Acta Pharmacol. Toxicol. 32:317-20
24. Goldstein A, Herrera J. 1995. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend. 40:139-50
25. Hughes J, Smith TW, Kosterliltz HW, Fothergill LA, Morgan BA, Morris HR. 1975. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258:577-79
26. Cox BM, Opheim KE, Teschemacher H, Goldstein A. 1975. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sci. 16:1777-82
27. Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L. 1979. Dynorphin-(1-13), an extraordinarily potent opioid peptide. Proc. Natl. Acad. Sci. USA 76:6666-70
28. Goldstein, A, Fischli W, Lowney LI, Hunkapiller M, Hood L. 1981. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide. Proc. Natl. Acad. Sci. USA 78:7219-23
29. Chavkin C, James IF, Goldstein A. 1982. Dynorphin is a specific endogenous ligand of the κ opioid receptor. Science 215:413-15
30. Goldstein A, Naidu A. 1989. Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol. Pharmacol. 36:265-72
31. Goldstein A, Barrett RW. 1987. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion. Mol. Pharmacol. 31:603-9
32. Xie GX, Miyajima A, Goldstein A. 1992. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands. Proc. Natl. Acad. Sci. USA 89:4124-28
33. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, et al. 1993. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc. Natl. Acad. Sci. USA 90:9954-58
34. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. 1992. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-52
35. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. 1992. Science 258:1952-55
36. Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. 1986. Morphine and codeine from mammalian brain. Proc. Natl. Acad. Sci. USA 83:9784-88
37. Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. 1988. 6-Acetylmorphine: a natural product present in mammalian brain. Proc. Natl. Acad. Sci. USA 85:5335-38
38. Judson BA, Himmelberger DU, Goldstein A. 1980. The naloxone test for opiate dependence. Clin. Pharmacol. Ther. 27:492-501
39. Judson BA, Goldstein A. 1979. Levoalpha-acetylmethadol (LAAM) in the treatment of heroin addicts. I. Dosage schedule for induction and stabilization. Drug Alcohol Depend. 4:461-66
40. Judson BA, Goldstein A, Inturrisi CE. 1983. Methadyl acetate (LAAM) in the treatment of heroin addicts. II. Double-blind comparison of gradual and abrupt detoxification. Arch. Gen. Psychiatry 40:834-40
41. Grevert P, Goldstein A. 1978. Endorphins: naloxone fails to alter experimental pain or mood in humans. Science 199:1093-95
42. Goldstein A. 1980. Thrills in response to music and other stimuli. Physiol. Psychol. 8:126-29
43. Leute RK, Ullman EF, Goldstein A, Herzenberg LA. 1972. Spin immunoassay technique for determination of morphine. Nat. New Biol. (London) 236:93-94
44. Goldstein A, Leute RK, Ullman EF. 1972. US Patent No. 3690834
45. Needels MC, Jones DG, Tate EH, Heinkel GL, Kochersperger LM, et al. 1993. Generation and screening of an oligonucleotide-encoded synthetic peptide library. Proc. Natl. Acad. Sci. USA 90:10700-4
46. Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L. 1990. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell 62:297-307
47. Hooke LP, He L, Lee NM. 1995. [Des-Tyrl]dynorphin A-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay. J. Pharmacol. Exp. Ther. 273:802-7
48. Goldstein A. 1978. IFR Principles and Practice: A Guide to Safe Instrument Flying. Long Beach, CA: Airguide. 124 pp.
49. Goldstein A. 1984. Flying Out of Danger: A Pilot's Guide to Safety. Long Beach, CA: Airguide. 140 pp.
50. Goldstein A. 1986. VFR Flight Review: A Guide to Better Flying. Stanford, CA: Avv A. 267 pp.
51. Goldstein A. 1986. The Right Seat: An Introduction to Flying for Pilots' Companions and Would-be Pilots. Stanford, CA: Avv A. 145 pp.
52. Chen XH, Han JS. 1992. All three types of opioid receptors in the spinal cord are important for 2/15 Hz electroacupuncture analgesia. Eur. J. Pharmacol. 211:203-10
53. Goldstein A. 1994. ADDICTION: From Biology to Drug Policy. New York: Freeman. 321 pp.
54. Goldstein A, Kalant H. 1990. Drug policy: striking the right balance. Science 249:1513-21